5,180
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response

, ORCID Icon, , , , , ORCID Icon, , , , , , , , , ORCID Icon, , & show all
Article: e1617588 | Received 14 Dec 2018, Accepted 01 May 2019, Published online: 04 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Adriana Petrazzuolo, M. Chiara Maiuri, Laurence Zitvogel, Guido Kroemer & Oliver Kepp. (2022) Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy. OncoImmunology 11:1.
Read now
Antoine Italiano. (2021) New insights into the clinical management of advanced gastrointestinal stromal tumors. Expert Opinion on Pharmacotherapy 22:4, pages 439-447.
Read now

Articles from other publishers (31)

Jinfen Wei, Wenqi Yu, Lei Wu, Zixi Chen, Guanda Huang, Meiling Hu & Hongli Du. (2023) Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types. Biomedicines 11:11, pages 3057.
Crossref
Jianrong Guo, Shoucheng Feng, Hong Liu, Zhuopeng Chen, Chao Ding, Yukai Jin, Xiaojiang Chen, Yudong Ling, Yi Zeng, Hao Long & Haibo Qiu. (2023) TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas. Biomolecules 13:9, pages 1298.
Crossref
Brian Effer, Isabela Perez, Daniel Ulloa, Carolyn Mayer, Francisca Muñoz, Diego Bustos, Claudio Rojas, Carlos Manterola, Luis Vergara-Gómez, Camila Dappolonnio, Helga Weber & Pamela Leal. (2023) Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. Biomedicines 11:7, pages 2086.
Crossref
Xiaolan Feng, Laurie Tonon, Haocheng Li, Elodie Darbo, Erin Pleasance, Nicolas Macagno, Armelle Dufresne, Mehdi Brahmi, Julien Bollard, Francoise Ducimetière, Marie Karanian, Alexandra Meurgey, Gaëlle Pérot, Thibaud Valentin, Frédéric Chibon & Jean-Yves Blay. (2023) Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers 15:14, pages 3705.
Crossref
Bo Li, Hui Chen, Shaohua Yang, Feng Chen, Liangliang Xu, Yan Li, Mingzhe Li, Chengming Zhu, Fangyuan Shao, Xinhua Zhang, Chuxia Deng, Leli Zeng, Yulong He & Changhua Zhang. (2023) Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. Molecular Cancer 22:1.
Crossref
Alessandra Dimino, Chiara Brando, Laura Algeri, Valerio Gristina, Erika Pedone, Marta Peri, Alessandro Perez, Ida De Luca, Roberta Sciacchitano, Luigi Magrin, Tancredi Didier Bazan Russo, Marco Bono, Nadia Barraco, Silvia Contino, Maria La Mantia, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan & Lorena Incorvaia. (2022) Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors. Cancers 15:1, pages 216.
Crossref
Hong Kyu Lee, Cho-Won Kim, Dohee Ahn, Ryeo-Eun Go, Youngdong Choi & Kyung-Chul Choi. (2022) Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma. Cancers 14:21, pages 5220.
Crossref
Wen-Kuan Huang, Chiao-En Wu, Shang-Yu Wang, Ching-Fu Chang, Wen-Chi Chou, Jen-Shi Chen & Chun-Nan Yeh. (2022) Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges. Current Treatment Options in Oncology 23:9, pages 1303-1319.
Crossref
Ashwyn K. Sharma, Teresa S. Kim, Sebastian Bauer & Jason K. Sicklick. (2022) Gastrointestinal Stromal Tumor. Surgical Oncology Clinics of North America 31:3, pages 431-446.
Crossref
Xiaoling Xu, Ding Wang, Na Li, Jiamin Sheng, Mingying Xie, Zichao Zhou, Guoping Cheng & Yun Fan. (2021) The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer. Annals of Surgical Oncology 29:5, pages 2930-2940.
Crossref
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier & François Bertucci. (2022) CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 14:5, pages 1306.
Crossref
Lizhu Liu, Lihong Wu, Dan Shan & Bo Han. (2022) Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers. Molecular Genetics and Genomics 297:2, pages 561-571.
Crossref
Vlad Herlea, Alexandra Roșulescu, Violeta Claudia Calotă, Vlad Croitoru, Elena Stoica Mustafa, Cătălin Vasilescu, Sorin Alexandrescu, Traian Dumitrașcu, Irinel Popescu, Simona Olimpia Dima & Maria Sajin. (2022) Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors. Medicina 58:2, pages 174.
Crossref
Xiangfei Sun, Ping Shu, Yong Fang, Wei Yuan, Qiang Zhang, Jianyi Sun, Min Fu, Anwei Xue, Xiaodong Gao, Kuntang Shen, Yingyong Hou, Yihong Sun, Jing Qin & Xinyu Qin. (2021) Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors. Frontiers in Oncology 11.
Crossref
Virinder Sarhadi, Binu Mathew, Arto Kokkola, Tiina Karla, Milja Tikkanen, Hilpi Rautelin, Leo Lahti, Pauli Puolakkainen & Sakari Knuutila. (2021) Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors. Gut Pathogens 13:1.
Crossref
Yan Zhao, Xinxin Liu, Keshuai Xiao, Liwen Wang, Yuping Li, Mingyun Kan & Zhiwei Jiang. (2021) Clinicopathological value of long non-coding RNA profiles in gastrointestinal stromal tumor. PeerJ 9, pages e11946.
Crossref
Matthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, Stéphane Champiat & Sarah Dumont. (2021) Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors. Frontiers in Immunology 12.
Crossref
Sebastian Bauer, Suzanne George, Margaret von Mehren & Michael C. Heinrich. (2021) Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor. Frontiers in Oncology 11.
Crossref
Sara Lettieri, Tiberio Oggionni, Andrea Lancia, Chandra Bortolotto & Giulia Maria Stella. (2021) Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?. International Journal of Molecular Sciences 22:6, pages 2882.
Crossref
Valentina Indio, Angela Schipani, Margherita Nannini, Milena Urbini, Alessandro Rizzo, Antonio De Leo, Annalisa Altimari, Valerio Di Scioscio, Daria Messelodi, Giuseppe Tarantino, Annalisa Astolfi & Maria Pantaleo. (2021) Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal Tumors. Journal of Clinical Medicine 10:5, pages 1057.
Crossref
Peigen Chen, Yu Zhang, Changyan Liang, Yuebo Yang, Yunhui li & Jing Wan. (2021) Classification of serous ovarian carcinoma based on immunogenomic profiling. International Immunopharmacology 91, pages 107274.
Crossref
Yilin Yan, Zhengnan Huang, Jinming Cai, Pengfei Tang, Fang Zhang, Mingyue Tan & Bing Shen. (2020) Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer. Aging 13:2, pages 2780-2802.
Crossref
Shuai Ye, Dinara Sharipova, Marya Kozinova, Lilli Klug, Jimson D’Souza, Martin G. Belinsky, Katherine J. Johnson, Margret B. Einarson, Karthik Devarajan, Yan Zhou, Samuel Litwin, Michael C. Heinrich, Ronald DeMatteo, Margaret von Mehren, James S. Duncan & Lori Rink. (2021) Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment. JCI Insight 6:2.
Crossref
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou & Michalis V. Karamouzis. (2021) Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. International Journal of Molecular Sciences 22:2, pages 493.
Crossref
Jomjit Chantharasamee, Jacob J. Adashek, Karlton Wong, Mark A. Eckardt, Bartosz Chmielowski, Sarah Dry, Fritz C. Eilber & Arun S. Singh. (2021) Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies. Current Treatment Options in Oncology 22:1.
Crossref
Caiyue Ren, Shengping Wang & Shengjian Zhang. (2020) Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. Cancer Imaging 20:1.
Crossref
Daniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, Davide Baldazzi, Monica Brenca, Alessia Mondello, Federica Nardi, Dominga Racanelli, Matilde Cacciatore, Angelo Paolo Dei Tos & Roberta Maestro. (2020) Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumors. JCI Insight 5:22.
Crossref
Yarne Klaver, Maud Rijnders, Astrid Oostvogels, Rebecca Wijers, Marcel Smid, Dirk Grünhagen, Kees Verhoef, Stefan Sleijfer, Cor Lamers & Reno Debets. (2020) Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes. Journal for ImmunoTherapy of Cancer 8:2, pages e000271.
Crossref
Valentina Indio, Gloria Ravegnini, Annalisa Astolfi, Milena Urbini, Maristella Saponara, Antonio De Leo, Elisa Gruppioni, Giuseppe Tarantino, Sabrina Angelini, Andrea Pession, Maria Abbondanza Pantaleo & Margherita Nannini. (2020) Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation. Frontiers in Immunology 11.
Crossref
Valentina Indio, Annalisa Astolfi, Milena Urbini, Margherita Nannini & Maria A Pantaleo. (2020) Genetics and treatment of gastrointestinal stromal tumors with immune checkpoint inhibitors: what do we know?. Pharmacogenomics 21:4, pages 231-234.
Crossref
Reham S. ElNemr Esmail, YousryW Nada, Amr Kamal, Hussein ElSayed & NohaM El-Anwer. (2020) Immunohistochemical characterization of immune cell infiltrate in gastrointestinal stromal tumor and its prognostic correlation. Egyptian Journal of Pathology 40:2, pages 229.
Crossref